Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS management praise dean for achievement
2004-08-17

 

 

Prof Letticia Moja was praised by Prof Frederick Fourie, Rector and Vice-Chancellor of the University of the Free State (UFS), and other members of management today for winning the education category of this year’s Shoprite Checkers/SABC2 Woman of the Year Award.

“We are extremely proud of Prof Moja with this prestigious achievement. It is also a feather in the cap for the UFS that our leaders are being recognised on a national level,” said Prof Fourie.

Prof Moja was appointed as Dean of the Faculty of Health Sciences at the end of last year, becoming the first woman to be appointed in this position at any medical faculty in the country.

“Prof Moja was nominated by her colleagues at the faculty. It is heart-warming to me that she made such an impact in the faculty in the short period since she was appointed as dean to be nominated for this prestigious award,” said Prof Fourie.

“On the nomination form, her colleagues wrote: ‘Prof Moja is not only a remarkable woman, but also a person with gifted qualities of leadership, dedication and compassion. She is blessed with the ability to listen to others, is an extremely reliable person and a competent leader’ – this makes her, in my view, a true winner”, said Prof Fourie.

Prof Moja was recently chosen as vice-president of the Health Professions Council and also serves on the Medical and Dental Board. Her involvement in these councils and committees enables her to represent women in general, as well as previous minority groups.

Prof Moja headed the Gynaecologic Oncology Unit at the Ga-Rankuwa Hospital in Pretoria from 1997 to February 2002, where after she was appointed as Vice-Dean at the UFS’s Faculty of Health Sciences and at the end of 2003 she was appointed in her current position. During her career, she has attended four international and eight local congresses, presented eight oral papers and four posters, was an author to one publication, co-authored four publications, was a guest editor to one publication and supervised three postgraduate publications.

MEDIA RELEASE
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept